Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

NewGenIvf Group Limited (NIVF)

Compare
0.3525
-0.0475
(-11.88%)
At close: 4:00:00 PM EDT
0.3921
+0.04
+(11.23%)
After hours: 4:16:44 PM EDT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Wing Fung Siu Co-Founder, Chairman & CEO -- -- 1956
Ms. Hei Yue Fong Co-Founder, Chief Marketing Officer & Director -- -- 1982
Mr. Fai Chung Ho Chief Financial Officer -- -- 1964

NewGenIvf Group Limited

Pier 2
1st Floor
Central, 999077
Hong Kong
852 2869 1088 https://newgenivf.com
Sector: 
Healthcare
Full Time Employees: 
70

Description

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's services include mitochondrial replacement (MRT) therapy in reproductive, intrauterine insemination, MRT techniques, intracytoplasmic sperm injection, semen analysis, testicular sperm extraction/testicular sperm aspiration/PESA, egg freezing, and chromosome screening. It also provides in vitro fertilization (IVF) treatment; surrogacy and ancillary caring services, including regular body check, as well as provision of vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. The company was founded in 2010 and is based in Central, Hong Kong.

Corporate Governance

NewGenIvf Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

April 11, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

March 7, 2025 at 12:00 AM UTC

F-1: Offering Registrations

February 20, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

February 7, 2025 at 12:00 AM UTC

6-K/A: Corporate Changes & Voting Matters

January 31, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

January 21, 2025 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

December 5, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

November 5, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

November 1, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

October 25, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

Related Tickers

SYRA Syra Health Corp.
0.1271
-37.94%
 
KDLY Kindly MD, Inc.
1.6600
-2.35%
 
NVOS Novo Integrated Sciences, Inc.
0.0011
-42.11%
 
CCM Concord Medical Services Holdings Limited
4.3000
+6.97%
 
MODV ModivCare Inc.
1.1250
+0.45%
 
PIII P3 Health Partners Inc.
9.82
+0.31%
 
TOI The Oncology Institute, Inc.
1.9400
+2.11%
 
NUTX Nutex Health Inc.
136.89
-1.50%
 
PACS PACS Group, Inc.
9.11
-0.98%
 
JNH.V Jack Nathan Medical Corp.
0.0100
0.00%